Trademark: 87461862
Status Date
Monday, December 28, 2020
Filing Date
Wednesday, May 24, 2017
Published for Opposition
Tuesday, September 26, 2017
Abandoned Date
Monday, December 28, 2020
5 Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; vaccines
Dec 28, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 28, 2020
Abandonment - No Use Statement Filed
May 28, 2020
Notice Of Approval Of Extension Request E-Mailed
May 27, 2020
Extension 5 Granted
May 12, 2020
Extension 5 Filed
May 27, 2020
Case Assigned To Intent To Use Paralegal
May 12, 2020
Teas Extension Received
Nov 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 4, 2019
Extension 4 Granted
Nov 4, 2019
Extension 4 Filed
Nov 4, 2019
Teas Extension Received
Apr 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2019
Extension 3 Granted
Apr 15, 2019
Extension 3 Filed
Apr 15, 2019
Teas Extension Received
Nov 20, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2018
Extension 2 Granted
Nov 16, 2018
Extension 2 Filed
Nov 16, 2018
Teas Extension Received
May 9, 2018
Notice Of Approval Of Extension Request E-Mailed
May 7, 2018
Extension 1 Granted
May 7, 2018
Extension 1 Filed
May 7, 2018
Teas Extension Received
Nov 21, 2017
Noa E-Mailed - Sou Required From Applicant
Sep 26, 2017
Official Gazette Publication Confirmation E-Mailed
Sep 26, 2017
Published For Opposition
Sep 6, 2017
Notification Of Notice Of Publication E-Mailed
Aug 17, 2017
Approved For Pub - Principal Register
Aug 16, 2017
Assigned To Examiner
May 31, 2017
New Application Office Supplied Data Entered In Tram
May 27, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
